系统性高血压对无临床糖尿病视网膜病变的糖尿病患者黄斑微血管的影响
这项回顾性横断面研究将受试者分为对照组、2型糖尿病组(DM组)和2型糖尿病合并高血压组(DM+HTN组),比较三组黄斑血管长度密度(VD)。结果显示三组VD分别为20.43±1.16、19.50±1.45和18.19±2.06 mm⁻¹(P<0.001),提示2型糖尿病患者的黄斑微血管受损,合并高血压者受损更重。
要点
- 2型糖尿病患者的黄斑血管长度密度较对照组降低。
- 合并高血压的2型糖尿病患者黄斑微血管损害较单纯糖尿病更严重。
- 高血压可能使黄斑微血管在高血糖下更易受损。
核心结论
- 2型糖尿病患者的黄斑微血管已存在损害,合并高血压者损害更重。
- 高血压造成的缺血条件可能使黄斑微血管更易受到高血糖损伤。
研究设计与样本
- 回顾性横断面研究,受试者分为对照组、2型糖尿病组和2型糖尿病合并高血压组。
- 比较三组黄斑血管长度密度(VD),并用线性回归分析VD的相关因素。
主要发现
- 对照组、DM组和DM+HTN组的VD分别为20.43±1.16、19.50±1.45和18.19±2.06 mm⁻¹(P<0.001)。
- 在2型糖尿病患者中,最佳矫正视力(B=-9.30;P=0.002)、2型糖尿病病程(B=-0.04;P=0.020)、高血压(B=-0.51;P=0.016)、信号强度(B=1.12;P<0.001)和神经节细胞-内丛状层厚度(B=0.06;P<0.001)是影响VD的显著因素。
- 在2型糖尿病合并高血压患者中,糖化血红蛋白(HbA1c)(B=-0.49;P=0.016)与VD显著相关。
临床怎么用
- 对无临床糖尿病视网膜病变的2型糖尿病患者,应关注其黄斑微血管状态。
- 合并高血压的2型糖尿病患者黄斑微血管损害更重,提示需重视血压管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify the impact of hypertension (HTN) on macular microvasculature in type 2 diabetes (T2DM) patients without clinical diabetic retinopathy. METHODS: In this retrospective cross-sectional study, subjects were divided into three groups: controls (control group), patients with T2DM (DM group), and patients with both T2DM and HTN (DM + HTN group). The vessel length density (VD) was compared among the groups. Linear regression analyses were performed to identify factors associated with VD. RESULTS: The VD in the control, DM, and DM + HTN groups was 20.43 ± 1.16, 19.50 ± 1.45, and 18.19 ± 2.06 mm-1, respectively (P < 0.001). The best-corrected visual acuity (B = -9.30; P = 0.002), duration of T2DM (B = -0.04; P = 0.020), HTN (B = -0.51; P = 0.016), signal strength (B = 1.12; P < 0.001), and ganglion cell-inner plexiform layer thickness (B = 0.06; P < 0.001) were significant factors affecting VD in patients with T2DM. Additionally, the hemoglobin A1c (HbA1c) (B = -0.49; P = 0.016) was significantly associated with VD in patients with both T2DM and HTN. CONCLUSIONS: Patients with T2DM had impaired macular microvasculature, and patients with T2DM with HTN exhibited greater impairment of the microvasculature than did patients with T2DM only. Additionally, physicians should be aware that the macular microvasculature would be more vulnerable to hyperglycemic damage under ischemic conditions by HTN.
引用
- Lee MW, Koo HM, Lee WH, et al. Impacts of Systemic Hypertension on the Macular Microvasculature in Diabetic Patients Without Clinical Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2021. PMID: 34546323. doi:10.1167/iovs.62.12.21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。